DaVita HealthCare Partners
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict DaVita HealthCare Partners's revenues will grow 45.2% and EPS will expand 23.3%.
The average estimate for revenue is $2.79 billion. On the bottom line, the average EPS estimate is $1.80.
Last quarter, DaVita HealthCare Partners logged revenue of $2.48 billion. GAAP reported sales were 41% higher than the prior-year quarter's $1.75 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.68. GAAP EPS of $1.51 for Q4 were 2.6% lower than the prior-year quarter's $1.55 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 31.3%, 210 basis points worse than the prior-year quarter. Operating margin was 16.1%, 390 basis points worse than the prior-year quarter. Net margin was 6.3%, 220 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $11.31 billion. The average EPS estimate is $7.55.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 325 members out of 338 rating the stock outperform, and 13 members rating it underperform. Among 96 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 94 give DaVita HealthCare Partners a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DaVita HealthCare Partners is outperform, with an average price target of $123.13.
Is DaVita HealthCare Partners the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add DaVita HealthCare Partners to My Watchlist.